semaglutide for ckd Mechanistic effects of on kidney disease in type 2 diabetes: The REMODEL trial" by Katherine Tuttle et al, was awarded with ISNWCN Preserving Kidney Health: Top Scored Abstract. Visual abstract by FDA Approves Semaglutide to Reduce

GLP-1 Pathway Formula: A comprehensive formula designed around GLP-1 related AMPK pathways, bringing together botanical compounds, probiotics, and metabolic* ingredients in one balanced composition

New study examines how the GLP-1 peptide semaglutide was associated with alcohol-related outcomes in adults with obesity and alcohol use disorder.

Explore the variety of weight loss shot as a contemporary approach to weight management

Subcutaneous semaglutide 2.4 mg injection is a glucagon-like peptide-1 (GLP-1) analogue approved by the European Medicines Agency as an adjunct to a reduced calorie diet and increased physical activity (diet and exercise, D&E) for the treatment obesity and overweight in the presence of at least one weight related comorbidity

Macadamia nuts are the richest source of MUFAs, shown to stimulate GLP-1 and support fat loss

Discover benefits, safety tips, and how to get started.